In recent years there has been increased cardiovascular morbidity, which is a significant cardiometabolic risk and has an essential role in the pathophysiology of arteriosclerosis, diabetes, and hormones like ghrelin and obestatin. This evidence concerns the gene GHRL and diabetes mellitus.